Tury S, Giovannini D, Ivanova S, Touhami J, Courgnaud V, Battini J
J Virol. 2022; 96(12):e0022922.
PMID: 35652657
PMC: 9215233.
DOI: 10.1128/jvi.00229-22.
Lopez-Sanchez U, Tury S, Nicolas G, Wilson M, Jurici S, Ayrignac X
J Biol Chem. 2020; 295(28):9366-9378.
PMID: 32393577
PMC: 7363132.
DOI: 10.1074/jbc.RA119.011376.
Lopez-Sanchez U, Nicolas G, Richard A, Maltete D, Charif M, Ayrignac X
Sci Rep. 2019; 9(1):6776.
PMID: 31043717
PMC: 6494797.
DOI: 10.1038/s41598-019-43255-x.
Kaulfuss M, Wensing I, Windmann S, Hrycak C, Bayer W
Retrovirology. 2017; 14(1):8.
PMID: 28166802
PMC: 5294899.
DOI: 10.1186/s12977-017-0336-7.
Legati A, Giovannini D, Nicolas G, Lopez-Sanchez U, Quintans B, Oliveira J
Nat Genet. 2015; 47(6):579-81.
PMID: 25938945
PMC: 4516721.
DOI: 10.1038/ng.3289.
Assisted evolution enables HIV-1 to overcome a high TRIM5α-imposed genetic barrier to rhesus macaque tropism.
Soll S, Wilson S, Kutluay S, Hatziioannou T, Bieniasz P
PLoS Pathog. 2013; 9(9):e1003667.
PMID: 24086139
PMC: 3784476.
DOI: 10.1371/journal.ppat.1003667.
Heterogeneous susceptibility of circulating SIV isolate capsids to HIV-interacting factors.
Mamede J, Sitbon M, Battini J, Courgnaud V
Retrovirology. 2013; 10:77.
PMID: 23883001
PMC: 3751554.
DOI: 10.1186/1742-4690-10-77.
Myocyte enhancer factor 2c, an osteoblast transcription factor identified by dimethyl sulfoxide (DMSO)-enhanced mineralization.
Stephens A, Stephens S, Hobbs C, Hutmacher D, Bacic-Welsh D, Woodruff M
J Biol Chem. 2011; 286(34):30071-86.
PMID: 21652706
PMC: 3191047.
DOI: 10.1074/jbc.M111.253518.
Homology-based identification of capsid determinants that protect HIV1 from human TRIM5α restriction.
Maillard P, Zoete V, Michielin O, Trono D
J Biol Chem. 2010; 286(10):8128-8140.
PMID: 21169362
PMC: 3048699.
DOI: 10.1074/jbc.M110.187609.
The mouse "xenotropic" gammaretroviruses and their XPR1 receptor.
Kozak C
Retrovirology. 2010; 7:101.
PMID: 21118532
PMC: 3009702.
DOI: 10.1186/1742-4690-7-101.
A novel envelope mediated post entry restriction of murine leukaemia virus in human cells is Ref1/TRIM5α independent.
Oliveira N, Trikha R, McKnight A
Retrovirology. 2010; 7:81.
PMID: 20929586
PMC: 2959036.
DOI: 10.1186/1742-4690-7-81.
The specificity of TRIM5 alpha-mediated restriction is influenced by its coiled-coil domain.
Maillard P, Ecco G, Ortiz M, Trono D
J Virol. 2010; 84(11):5790-801.
PMID: 20219908
PMC: 2876608.
DOI: 10.1128/JVI.02413-09.
The prostate cancer-associated human retrovirus XMRV lacks direct transforming activity but can induce low rates of transformation in cultured cells.
Metzger M, Holguin C, Mendoza R, Miller A
J Virol. 2009; 84(4):1874-80.
PMID: 20007266
PMC: 2812358.
DOI: 10.1128/JVI.01941-09.
Multi-stage Friend murine erythroleukemia: molecular insights into oncogenic cooperation.
Moreau-Gachelin F
Retrovirology. 2008; 5:99.
PMID: 18983647
PMC: 2585586.
DOI: 10.1186/1742-4690-5-99.
Evidence for restriction of ancient primate gammaretroviruses by APOBEC3 but not TRIM5alpha proteins.
Perez-Caballero D, Soll S, Bieniasz P
PLoS Pathog. 2008; 4(10):e1000181.
PMID: 18927623
PMC: 2564838.
DOI: 10.1371/journal.ppat.1000181.
Novel postentry resistance to AKV ecotropic mouse gammaretroviruses in the African pygmy mouse, Mus minutoides.
Yan Y, Kozak C
J Virol. 2008; 82(13):6120-9.
PMID: 18417580
PMC: 2447103.
DOI: 10.1128/JVI.00202-08.
Interfering residues narrow the spectrum of MLV restriction by human TRIM5alpha.
Maillard P, Reynard S, Serhan F, Turelli P, Trono D
PLoS Pathog. 2008; 3(12):e200.
PMID: 18166079
PMC: 2156100.
DOI: 10.1371/journal.ppat.0030200.
The Tom1L1-clathrin heavy chain complex regulates membrane partitioning of the tyrosine kinase Src required for mitogenic and transforming activities.
Collin G, Franco M, Simon V, Benistant C, Roche S
Mol Cell Biol. 2007; 27(21):7631-40.
PMID: 17785434
PMC: 2169060.
DOI: 10.1128/MCB.00543-07.
Fusion of cyclophilin A to Fv1 enables cyclosporine-sensitive restriction of human and feline immunodeficiency viruses.
Schaller T, Ylinen L, Webb B, Singh S, Towers G
J Virol. 2007; 81(18):10055-63.
PMID: 17609268
PMC: 2045386.
DOI: 10.1128/JVI.00616-07.
Characterization of an amino-terminal dimerization domain from retroviral restriction factor Fv1.
Bishop K, Mortuza G, Howell S, Yap M, Stoye J, Taylor I
J Virol. 2006; 80(16):8225-35.
PMID: 16873278
PMC: 1563794.
DOI: 10.1128/JVI.00395-06.